Our exploration indicated that most tyrosine metabolism-related enzymes, including TAT, HPD, DDC, GOT1, COMT, GSTZ1, LCMT1, and FAH, were significantly upregulated, while GOT2 and ADH5 were significantly deregulated in prostate cancer samples. This evidence concerns the gene GOT1 and prostate cancer.